All News about Recursion Pharmaceuticals Inc Cl A
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
Analyst Expectations for Recursion Pharmaceuticals's Future
August 09, 2023
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2023/05/artificial-intelligence-ai-stocks-robot-hand-1600.jpg)
![](https://www.globenewswire.com/Content/Images/intrado.png)
![](https://ml.globenewswire.com/media/9c3f7e67-3394-4aee-b77d-68f288ea03a7/small/recursion-logo-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/Cathie_Wood_Ark_Photo_courtesy_Benzinga_YouTube_and_Unsplash_24.jpeg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/741875/research-scientists-drugs-pharma-biotech.jpg)
![](https://www.globenewswire.com/Content/Images/intrado.png)
Recursion to Participate in Upcoming Investor Conference
August 01, 2023
Via GlobeNewswire
![](https://www.marketbeat.com/logos/articles/med_20230731133815_here-are-3-ai-drug-discovery-stocks-to-put-on-your.jpg)
Here are 3 AI Drug Discovery Stocks to Put on Your Watchlist
August 01, 2023
Via MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
![](https://cdn.benzinga.com/files/images/story/2023/options_image_0.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://www.marketbeat.com/logos/articles/med_20230728075225_biotech-healthcare-meet-ai-stocks-soar-on-innovati.jpg)
![](https://www.marketbeat.com/logos/articles/med_20230725084430_exscientia-is-the-sniper-of-the-ai-drug-discovery.jpg)
![](https://investorplace.com/wp-content/uploads/2023/05/nvda1600-4.png)
![](https://www.globenewswire.com/Content/Images/intrado.png)
![](https://www.marketbeat.com/images/256x256-marketbeat-icon.png?v=2023)
![](https://g.foolcdn.com/editorial/images/740326/scientists-high-five-smile.jpg)
![](https://investorplace.com/wp-content/uploads/2023/07/rxrx1600-1024x576.png)
![](https://cdn.benzinga.com/files/images/story/2023/07/19/att_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2023/05/nvda1600-4.png)
![](https://g.foolcdn.com/editorial/images/739858/a-young-scientist-recording-her-findings-on-a-tablet.jpg)
![](https://g.foolcdn.com/editorial/images/739830/investor-sitting-at-computer-with-pen.jpg)
![](https://investorplace.com/wp-content/uploads/2023/05/nvda1600-4.png)
![](https://images.pexels.com/photos/2280549/pexels-photo-2280549.jpeg?auto=compress&cs=tinysrgb&h=750&w=1260)
![](https://www.marketbeat.com/logos/articles/med_20230717063603_nvidia-invested-50-million-into-this-ai-drug-disco.jpg)
![](https://investorplace.com/wp-content/uploads/2019/07/biotech1600d.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/07/14/stock_whisper_index_logo_6_copy.jpeg?width=1200&height=800&fit=crop)
![](https://g.foolcdn.com/editorial/images/739722/artificial-intelligence-ai-on-cloud-circuit-board.jpg)
![](https://investorplace.com/wp-content/uploads/2023/07/rxrx1600-1024x576.png)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Subscribe Now